EFFICACY OF TOPICAL TACROLIMUS 0.05% SUSPENSION ON TREATMENT OF STEROID RESISTANT REFRACTORY VERNAL KERATOCONJUNCTIVITIS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

BARADARAN RAFII A.R.; AKBARI M.; SADOUGHI M.M.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: BINA Year:2014 | Volume:19 | Issue:2 (75) Page(s): 99-109

Download Full-Text

Persian Verion

View:

1,374

Download:

Cites:

Information Journal Paper

Title

EFFICACY OF TOPICAL TACROLIMUS 0.05% SUSPENSION ON TREATMENT OF STEROID RESISTANT REFRACTORY VERNAL KERATOCONJUNCTIVITIS

Author(s)

BARADARAN RAFII A.R. | AKBARI M. | SADOUGHI M.M. | Issue Writer Certificate

Keywords

REFRACTORYQ3

STEROID RESISTANTQ3

TACROLIMUSQ3

VERNAL KERATOCONJUNCTIVITISQ3

VKCQ3

Abstract

Purpose: To evaluate the efficacy and safety of topical TACROLIMUS 0.05% suspension for the treatment of long standing STEROID RESISTANT VERNAL KERATOCONJUNCTIVITIS (VKC).Methods: In this interventional case series, patients with REFRACTORY VKC were included. All patients had active symptomatic disease despite conventional medical therapy including topical steroids. After discontinuation of all the medications, patients were treated with topical 0.05% TACROLIMUS eye drop four times a day for at leastr 6 months. Changes in subjective symptoms and objective signs scores after treatment were evaluated one week, one month and 6 months after treatment. Development of possible ocular and systemic complications were also assessed.Results: Twenty-eight eyes of 14 patients, 11 male and 4 female were included. Mean age of the patients was 22±8 years (11 to 38 years). Mean duration of VKC was12±6 years (5 to 23 years). Patients were followed for 10±2 months (6-12 months). All symptoms including itching, redness, photosensitivity, foreign body sensation and mucus discharge improved in all follow-up periods (P<.001). Conjunctival hyperemia was the first sign, which improved 1 week after treatment. Other objective signs including conjunctival papillary hypertrophy, limbal hypertrophy (including Horner-Trantas dots), corneal punctate epithelial erosions and corneal pannus decreased at least one month after treatment. There was no changes in corneal opacity during follow-up period (p>0.05). No ocular or systemic complications was observed.Conclusion: Topical 0.05% TACROLIMUS is a safe and effective medication for steroid-resistant REFRACTORY VKC. It might be better to apply it earlier in these cases before occurance of the complications including irreversible limbal stem cell deficiency and corneal opacity and steroid-induced complications. However, long-term use was needed to control the disease.

Cites

No record.

References

No record.

Cite

APA: Copy

BARADARAN RAFII, A.R., AKBARI, M., & SADOUGHI, M.M.. (2014). EFFICACY OF TOPICAL TACROLIMUS 0.05% SUSPENSION ON TREATMENT OF STEROID RESISTANT REFRACTORY VERNAL KERATOCONJUNCTIVITIS. BINA, 19(2 (75)), 99-109. SID. https://sid.ir/paper/42751/en

Vancouver: Copy

BARADARAN RAFII A.R., AKBARI M., SADOUGHI M.M.. EFFICACY OF TOPICAL TACROLIMUS 0.05% SUSPENSION ON TREATMENT OF STEROID RESISTANT REFRACTORY VERNAL KERATOCONJUNCTIVITIS. BINA[Internet]. 2014;19(2 (75)):99-109. Available from: https://sid.ir/paper/42751/en

IEEE: Copy

A.R. BARADARAN RAFII, M. AKBARI, and M.M. SADOUGHI, “EFFICACY OF TOPICAL TACROLIMUS 0.05% SUSPENSION ON TREATMENT OF STEROID RESISTANT REFRACTORY VERNAL KERATOCONJUNCTIVITIS,” BINA, vol. 19, no. 2 (75), pp. 99–109, 2014, [Online]. Available: https://sid.ir/paper/42751/en

Related Journal Papers